Michael Anstey - Net Worth and Insider Trading
Michael Anstey Net Worth
The estimated net worth of Michael Anstey is at least $44 Million dollars as of 2024-11-10. Michael Anstey is the Director of Bicycle Therapeutics PLC and owns about 1,751,437 shares of Bicycle Therapeutics PLC (BCYC) stock worth over $44 Million. Details can be seen in Michael Anstey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Anstey has not made any transactions after 2019-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Anstey
Michael Anstey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Anstey owns 1 companies in total, including Bicycle Therapeutics PLC (BCYC) .
Click here to see the complete history of Michael Anstey’s form 4 insider trades.
Insider Ownership Summary of Michael Anstey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2019-05-28 | director |
Michael Anstey Latest Holdings Summary
Michael Anstey currently owns a total of 1 stock. Michael Anstey owns 1,751,437 shares of Bicycle Therapeutics PLC (BCYC) as of May 28, 2019, with a value of $44 Million.
Latest Holdings of Michael Anstey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2019-05-28 | 1,751,437 | 25.00 | 43,785,925 |
Holding Weightings of Michael Anstey
Michael Anstey Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Anstey has made a total of 0 transactions in Bicycle Therapeutics PLC (BCYC) over the past 5 years. The most-recent trade in Bicycle Therapeutics PLC is the acquisition of 314,286 shares on May 28, 2019, which cost Michael Anstey around $4 Million.
Insider Trading History of Michael Anstey
- 1
Michael Anstey Trading Performance
GuruFocus tracks the stock performance after each of Michael Anstey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Anstey is -45.11%. GuruFocus also compares Michael Anstey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Anstey within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Anstey's insider trading performs compared to the benchmark.
Performance of Michael Anstey
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.08 | | | | | |
| Relative Return to S&P 500(%) | -23.05 | | | | | |
Michael Anstey Ownership Network
Ownership Network List of Michael Anstey
Ownership Network Relation of Michael Anstey
Michael Anstey Owned Company Details
What does Bicycle Therapeutics PLC do?
Who are the key executives at Bicycle Therapeutics PLC?
Michael Anstey is the director of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Business Officer Nigel Crockett , Chief Accounting Officer Travis Alvin Thompson , and Chief Operating Officer Alistair Milnes .
Bicycle Therapeutics PLC (BCYC) Insider Trades Summary
Over the past 18 months, Michael Anstey made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 21,235 shares made by Kevin Lee , a net sale of 6,430 shares made by Michael Skynner , and a net sale of 6,430 shares made by Nigel Crockett .
In summary, during the past 3 months, insiders sold 6,528 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 6,528 shares. During the past 18 months, 47,264 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 47,264 shares.
Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bicycle Therapeutics PLC Insider Transactions
Michael Anstey Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Anstey. You might contact Michael Anstey via mailing address: C/o Bicycle Therapeutics Limited, B900 Babraham Research Campus, Cambridge X0 Cb22 3at.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
